https://doi.org/10.1016/j.bjhh.2015.03.017
R
Renata de Oliveira Costa
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
31
Papers
116
Citations
7
h-index
4
i10-index
Renata de Oliveira Costa is an academic researcher from Centro Universitário Lusíada. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Viral-associated cancers and disorders & Chronic Lymphocytic Leukemia Research. The author has an h-index of 7, co-authored 27 publications.
ORCID: 0000-0002-3345-3546Papers by this author
worksPrimary nodal peripheral T-cell lymphomas: diagnosis and therapeutic considerations
2015 · Revista Brasileira de Hematologia e Hemoterapia · 15 citations
Predictors of Survival, Treatment Modalities, and Clinical Outcomes of Diffuse Large B-Cell Lymphoma in Patients Older Than 70 Years Still an Unmet Medical Need in 2024 Based on Real-World Evidence
2024 · Cancers · 9 citations
https://doi.org/10.3390/cancers16081459
Overexpression of OCT-1 gene is a biomarker of adverse prognosis for diffuse large B-cell lymphoma (DLBCL): data from a retrospective cohort of 77 Brazilian patients
2020 · BMC Cancer · 6 citations
https://doi.org/10.1186/s12885-020-07553-2
Tumor mutation burden involving epigenetic regulatory genes and the RhoA GTPase predicts overall survival in nodal mature T-cell lymphomas
2022 · Clinical Epigenetics · 5 citations
https://doi.org/10.1186/s13148-022-01395-4
“H” is not for hydroxychloroquine—“H” is for heparin: lack of efficacy of hydroxychloroquine and the role of heparin in COVID-19—preliminary data of a prospective and interventional study from Brazil
2022 · BMC Infectious Diseases · 1 citations
https://doi.org/10.1186/s12879-022-07110-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat